Literature DB >> 30838228

An Update on the Hereditary Spastic Paraplegias: New Genes and New Disease Models.

Kishore R Kumar1, Nicholas F Blair1, Carolyn M Sue1.   

Abstract

AIMS: The hereditary spastic paraplegias (HSPs) are a heterogeneous group of disorders characterized by spasticity in the lower limbs. We provide an overview of HSP with an emphasis on recent developments.
METHODS: A PubMed search using the term "hereditary spastic paraplegia" and "hereditary spastic paraparesis" was conducted for a period from January 2012 to January 2015. We discuss and critique the major studies in the field over this 36-month period.
RESULTS: A total of 346 publications were identified, of which 47 were selected for review. We provide an update of the common forms of HSP and include patient videos. We also discuss how next-generation sequencing (NGS) has led to the accelerated discovery of new HSP genes, including B4GALNT1,DDHD1, C19orf12,GBA2,TECPR2,DDHD2, C12orf65,REEP2, and IBA57. Moreover, a single study alone identified 18 previously unknown putative HSP genes and created a model for the protein interactions of HSP, called the "HSPome." Many of the newly reported genes cause rare, complicated, autosomal recessive forms of HSP. NGS also has important clinical applications by facilitating the molecular diagnosis of HSP. Furthermore, common genetic forms of HSP have been studied using new disease models, such as neurons derived from induced pluripotent stem cells. These models have been used to elucidate important disease mechanisms and have served as platforms to screen for candidate drug compounds.
CONCLUSION: The field of HSP research has been progressing at a rapid pace. The challenge remains in translating these advances into new targeted disease therapies.

Entities:  

Keywords:  hereditary spastic paraplegia; next generation sequencing; review

Year:  2015        PMID: 30838228      PMCID: PMC6353461          DOI: 10.1002/mdc3.12184

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  74 in total

1.  Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia.

Authors:  J Hazan; N Fonknechten; D Mavel; C Paternotte; D Samson; F Artiguenave; C S Davoine; C Cruaud; A Dürr; P Wincker; P Brottier; L Cattolico; V Barbe; J M Burgunder; J F Prud'homme; A Brice; B Fontaine; B Heilig; J Weissenbach
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

2.  Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia.

Authors:  X Zhao; D Alvarado; S Rainier; R Lemons; P Hedera; C H Weber; T Tukel; M Apak; T Heiman-Patterson; L Ming; M Bui; J K Fink
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

3.  Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31.

Authors:  Stephan Züchner; Gaofeng Wang; Khanh-Nhat Tran-Viet; Martha A Nance; Perry C Gaskell; Jeffery M Vance; Allison E Ashley-Koch; Margaret A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2006-05-26       Impact factor: 11.025

4.  SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years.

Authors:  M Namekawa; P Ribai; I Nelson; S Forlani; F Fellmann; C Goizet; C Depienne; G Stevanin; M Ruberg; A Dürr; A Brice
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

5.  Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration.

Authors:  Giovanni Stevanin; Hamid Azzedine; Paola Denora; Amir Boukhris; Meriem Tazir; Alexander Lossos; Alberto Luis Rosa; Israela Lerer; Abdelmadjid Hamri; Paulo Alegria; José Loureiro; Masayoshi Tada; Didier Hannequin; Mathieu Anheim; Cyril Goizet; Victoria Gonzalez-Martinez; Isabelle Le Ber; Sylvie Forlani; Kiyoshi Iwabuchi; Vardiela Meiner; Goekhan Uyanik; Anne Kjersti Erichsen; Imed Feki; Florence Pasquier; Soreya Belarbi; Vitor T Cruz; Christel Depienne; Jeremy Truchetto; Guillaume Garrigues; Chantal Tallaksen; Christine Tranchant; Masatoyo Nishizawa; José Vale; Paula Coutinho; Filippo M Santorelli; Chokri Mhiri; Alexis Brice; Alexandra Durr
Journal:  Brain       Date:  2007-12-13       Impact factor: 13.501

6.  Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration.

Authors:  Maria K Tsaousidou; Karim Ouahchi; Tom T Warner; Yi Yang; Michael A Simpson; Nigel G Laing; Philip A Wilkinson; Ricardo E Madrid; Heema Patel; Faycal Hentati; Michael A Patton; Afif Hentati; Philippa J Lamont; Teepu Siddique; Andrew H Crosby
Journal:  Am J Hum Genet       Date:  2008-01-18       Impact factor: 11.025

7.  Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum.

Authors:  Giovanni Stevanin; Filippo M Santorelli; Hamid Azzedine; Paula Coutinho; Jacques Chomilier; Paola S Denora; Elodie Martin; Anne-Marie Ouvrard-Hernandez; Alessandra Tessa; Naïma Bouslam; Alexander Lossos; Perrine Charles; José L Loureiro; Nizar Elleuch; Christian Confavreux; Vítor T Cruz; Merle Ruberg; Eric Leguern; Djamel Grid; Meriem Tazir; Bertrand Fontaine; Alessandro Filla; Enrico Bertini; Alexandra Durr; Alexis Brice
Journal:  Nat Genet       Date:  2007-02-18       Impact factor: 38.330

8.  Intramuscular viral delivery of paraplegin rescues peripheral axonopathy in a model of hereditary spastic paraplegia.

Authors:  Marinella Pirozzi; Angelo Quattrini; Gennaro Andolfi; Giorgia Dina; Maria Chiara Malaguti; Alberto Auricchio; Elena I Rugarli
Journal:  J Clin Invest       Date:  2005-12-15       Impact factor: 14.808

9.  Disease-related phenotypes in a Drosophila model of hereditary spastic paraplegia are ameliorated by treatment with vinblastine.

Authors:  Genny Orso; Andrea Martinuzzi; Maria Giovanna Rossetto; Elena Sartori; Mel Feany; Andrea Daga
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

10.  The extent of axonal loss in the long tracts in hereditary spastic paraplegia.

Authors:  G C Deluca; G C Ebers; M M Esiri
Journal:  Neuropathol Appl Neurobiol       Date:  2004-12       Impact factor: 8.090

View more
  7 in total

Review 1.  Genotype-phenotype associations in hereditary spastic paraplegia: a systematic review and meta-analysis on 13,570 patients.

Authors:  Maryam Erfanian Omidvar; Shahram Torkamandi; Somaye Rezaei; Behnam Alipoor; Mir Davood Omrani; Hossein Darvish; Hamid Ghaedi
Journal:  J Neurol       Date:  2019-11-19       Impact factor: 4.849

2.  Clinical Features and Genetic Spectrum of Patients With Clinically Suspected Hereditary Progressive Spastic Paraplegia.

Authors:  Yuzhi Shi; An Wang; Bin Chen; Xingao Wang; Songtao Niu; Wei Li; Shaowu Li; Zaiqiang Zhang
Journal:  Front Neurol       Date:  2022-04-28       Impact factor: 4.086

Review 3.  Importance of lipids for upper motor neuron health and disease.

Authors:  Aksu Gunay; Heather H Shin; Oge Gozutok; Mukesh Gautam; P Hande Ozdinler
Journal:  Semin Cell Dev Biol       Date:  2020-12-13       Impact factor: 7.727

4.  Motor Evoked Potentials in Hereditary Spastic Paraplegia-A Systematic Review.

Authors:  Sue-Faye Siow; Ruaridh Cameron Smail; Karl Ng; Kishore R Kumar; Carolyn M Sue
Journal:  Front Neurol       Date:  2019-09-18       Impact factor: 4.003

Review 5.  Challenges and Controversies in the Genetic Diagnosis of Hereditary Spastic Paraplegia.

Authors:  Lydia Saputra; Kishore Raj Kumar
Journal:  Curr Neurol Neurosci Rep       Date:  2021-02-28       Impact factor: 5.081

Review 6.  Childhood-onset hereditary spastic paraplegia and its treatable mimics.

Authors:  Darius Ebrahimi-Fakhari; Afshin Saffari; Phillip L Pearl
Journal:  Mol Genet Metab       Date:  2021-06-24       Impact factor: 4.797

Review 7.  Disease-Associated Mutations in the HSPD1 Gene Encoding the Large Subunit of the Mitochondrial HSP60/HSP10 Chaperonin Complex.

Authors:  Peter Bross; Paula Fernandez-Guerra
Journal:  Front Mol Biosci       Date:  2016-08-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.